UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 206

Sortiert nach

The SOFA score-development, utility and challenges of accurate assessment in clinical trials

Critical care (London, England), 2019-11, Vol.23 (1), p.374-374, Article 374

2019

Link zum Volltext

Verfügbarkeit prüfen

Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients

Critical care (London, England), 2017-08, Vol.21 (1), p.213-213, Article 213

2017

Link zum Volltext

Verfügbarkeit prüfen

Adrenal function in sepsis: The retrospective Corticus cohort study

Critical care medicine, 2007-04, Vol.35 (4), p.1012-1018

2007

Link zum Volltext

Verfügbarkeit prüfen

Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress Syndrome

The New England journal of medicine, 2004-08, Vol.351 (9), p.884-892

2004

Link zum Volltext

Verfügbarkeit prüfen

Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis

The New England journal of medicine, 2001-03, Vol.344 (10), p.699-709

2001

Link zum Volltext

Verfügbarkeit prüfen

Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study

Critical care medicine, 2005-05, Vol.33 (5), p.952-961

2005

Link zum Volltext

Verfügbarkeit prüfen

Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study

ERJ open research, 2023-01, Vol.9 (1), p.342

2023

Link zum Volltext

Verfügbarkeit prüfen

The challenge of ventilator-associated pneumonia diagnosis in COVID-19 patients

Critical care (London, England), 2020-06, Vol.24 (1), p.289-289, Article 289

2020

Link zum Volltext

Verfügbarkeit prüfen

Myeloid-related protein-8/14 facilitates bacterial growth during pneumococcal pneumonia

Thorax, 2014-11, Vol.69 (11), p.1034-1042

2014

Link zum Volltext

Verfügbarkeit prüfen

Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]

Critical care (London, England), 2004-04, Vol.8 (2), p.R82-R90

2004

Link zum Volltext

Verfügbarkeit prüfen

Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis

Critical care (London, England), 2020-07, Vol.24 (1), p.410-410, Article 410

2020

Link zum Volltext

Verfügbarkeit prüfen

Convalescent Plasma for Covid-19-Induced ARDS. Reply

The New England journal of medicine, 2024-01, Vol.390 (4), p.386-386

2024

Link zum Volltext

Verfügbarkeit prüfen

Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19–related Acute Respiratory Distress Syndrome

American journal of respiratory and critical care medicine, 2021-11, Vol.204 (9), p.1024-1034

2021

Link zum Volltext

Verfügbarkeit prüfen

Aerosol delivery during invasive mechanical ventilation: a systematic review

Critical care (London, England), 2017-10, Vol.21 (1), p.264-264, Article 264

2017

Link zum Volltext

Verfügbarkeit prüfen

New Agents in Development for Sepsis: Any Reason for Hope?

Drugs (New York, N.Y.), 2020-11, Vol.80 (17), p.1751-1761

2020

Link zum Volltext

Verfügbarkeit prüfen

CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial

The Lancet infectious diseases, 2019-06, Vol.19 (6), p.620-630

2019

Link zum Volltext

Verfügbarkeit prüfen

Impact of Very Early Physical Therapy During Septic Shock on Skeletal Muscle: A Randomized Controlled Trial

Critical care medicine, 2018-09, Vol.46 (9), p.1436-1443

2018

Link zum Volltext

Verfügbarkeit prüfen

The INHALE trial: multiple reasons for a negative result

The Lancet infectious diseases, 2020-07, Vol.20 (7), p.778-779

2020

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapies for COVID-19: lessons learned from sepsis

The lancet respiratory medicine, 2020-10, Vol.8 (10), p.946-949

2020

Link zum Volltext

Verfügbarkeit prüfen

Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study

Critical care (London, England), 2018-01, Vol.22 (1), p.8-8, Article 8

2018

Link zum Volltext

Verfügbarkeit prüfen

Beyond antibiotics in severe community-acquired pneumonia: the role and rationale for tissue factor pathway inhibition

Critical care (London, England), 2008-01, Vol.12 Suppl 6 (Suppl 6), p.S4-S4

Laterre, Pierre-Francois

2008

Link zum Volltext

Verfügbarkeit prüfen

Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures

PloS one, 2016-05, Vol.11 (5), p.e0156299-e0156299

2016

Link zum Volltext

Verfügbarkeit prüfen

Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial

Critical care medicine, 2004-02, Vol.32 (2), p.332-341

2004

Link zum Volltext

Verfügbarkeit prüfen

Neutrophil-to-Lymphocyte Ratio Predicts Death in Acute-on-Chronic Liver Failure Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study

Shock (Augusta, Ga.), 2018-04, Vol.49 (4), p.385-392

2018

Link zum Volltext

Verfügbarkeit prüfen

Improving the management of severe acute pancreatitis: The new guidelines from the French Society of Anaesthesia and Intensive Care Medicine

Anaesthesia critical care & pain medicine, 2022-06, Vol.41 (3), p.101103-101103, Article 101103

2022

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 206

Suche als RSS-Feed

Aktive Filter

KollektionSpringerLINK Contemporary (Konsortium Baden-Württemberg)

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(192)
Mit Volltextzugriff
(192)

Publikationsform

Sprache

Englisch
(203)
Japanisch
(23)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The SOFA score-development, utility and challenges of accurate assessment in clinical trials

Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients

Adrenal function in sepsis: The retrospective Corticus cohort study

Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress Syndrome

Efficacy and Safety of Recombinant Human Activated Protein C for Severe Sepsis

Severe community-acquired pneumonia as a cause of severe sepsis: Data from the PROWESS study

Circulating dipeptidyl peptidase 3 and bio-adrenomedullin levels are associated with impaired outcomes in critically ill COVID-19 patients: a prospective international multicentre study

The challenge of ventilator-associated pneumonia diagnosis in COVID-19 patients

Myeloid-related protein-8/14 facilitates bacterial growth during pneumococcal pneumonia

Universal changes in biomarkers of coagulation and inflammation occur in patients with severe sepsis, regardless of causative micro-organism [ISRCTN74215569]

Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis

Convalescent Plasma for Covid-19-Induced ARDS. Reply

Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19–related Acute Respiratory Distress Syndrome

Aerosol delivery during invasive mechanical ventilation: a systematic review

New Agents in Development for Sepsis: Any Reason for Hope?

CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial

Impact of Very Early Physical Therapy During Septic Shock on Skeletal Muscle: A Randomized Controlled Trial

The INHALE trial: multiple reasons for a negative result

Immunotherapies for COVID-19: lessons learned from sepsis

Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study

Beyond antibiotics in severe community-acquired pneumonia: the role and rationale for tissue factor pathway inhibition

Clinical Impact of MALDI-TOF MS Identification and Rapid Susceptibility Testing on Adequate Antimicrobial Treatment in Sepsis with Positive Blood Cultures

Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial

Neutrophil-to-Lymphocyte Ratio Predicts Death in Acute-on-Chronic Liver Failure Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study

Improving the management of severe acute pancreatitis: The new guidelines from the French Society of Anaesthesia and Intensive Care Medicine

Aktive Filter

Suchergebnisse filtern